New data from clinical trials of the AstraZeneca-Oxford University COVID-19 vaccine suggest it provides strong protection after the first of two doses and could slow the spread of the virus, according to a new preprint study.The development comes amid a flurry of other vaccine developments today and as health officials look more toward spacing out the two-dose vaccines as a way to protect more people, especially as the threat of more transmissible variants and ones that can escape immunity darken the horizon.Data affirm UK prime-boost timingIn a preprint in The Lancet, researchers published another month's worth of data and combined findings from four trials that took place in the United Kingdom, South Africa, and Brazil.
Read more on cidrap.umn.edu